ARCHIVES

Neulasta Reduces Incidence Of Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: ACOS Moves Up Schedule for TNM Staging System From 1986 To “As Expeditiously As Possible”

January 13, 1984

NCI to Recompete contracts for Frederick

December 4, 1992

Control AC Hear Report On High Risk conference, Messer Survey

September 6, 1974

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

April 26, 1996

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

NCI contract Award

August 1, 1997